11 studies found for:    PSEN1
Show Display Options
Rank Status Study
1 Recruiting A Study of Crenezumab Versus Placebo in Preclinical PSEN1 E280A Mutation Carriers to Evaluate Efficacy and Safety in the Treatment of Autosomal-Dominant Alzheimer Disease, Including a Placebo-Treated Noncarrier Cohort.
Condition: Alzheimer Disease
Interventions: Drug: crenezumab;   Drug: placebo
2 Recruiting Central and Systemic Inflammation in Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention:
3 Unknown  Genetics of Mendelian Forms of Young Onset Alzheimer Disease
Condition: Autosomal Dominant Cases of Alzheimer 's Disease
Intervention:
4 Active, not recruiting Long Term Safety and Efficacy Study of ProSavin in Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Drug: ProSavin
5 Recruiting Cabazitaxel vs. Vinflunine in Metastatic or Locally Advanced Transitional Cell Carcinoma of the Urothelium (TCCU)
Condition: Urothelium Transitional Cell Carcinoma
Interventions: Drug: Cabazitaxel;   Drug: Vinflunine
6 Unknown  Clinical and Genetic Study of Neurodegenerative Disorders With Cognitive Impairment
Conditions: Alzheimer's Disease;   Dementia;   Neurodegenerative Disorders
Intervention: Other: Blood sampling, skin biopsy
7 Recruiting Dominantly Inherited Alzheimer Network (DIAN)
Condition: Alzheimer's Disease
Intervention:
8 Terminated
Has Results
Weekly Oxaliplatin and Gemcitabine for Recurrent or Metastatic Head and Neck Cancer
Condition: Cancer of the Head and Neck
Interventions: Drug: Gemcitabine;   Drug: Oxaliplatin
9 Recruiting Clinical Trial: Effectiveness and Efficiency of Physical Exercise in Cancer Patients
Conditions: Non-Small-Cell Lung Carcinoma;   Digestive System Neoplasms;   Breast Neoplasms
Interventions: Other: Supervised Physical activity;   Behavioral: education program on healthy habits
10 Recruiting Ursodeoxycholic Acid as Treatment for Polycystic Liver Disease
Conditions: Polycystic Liver Disease (PLD):;   Polycystic Kidney, Autosomal Dominant;   Polycystic Liver Disease
Intervention: Drug: Ursodeoxycholic Acid
11 Recruiting Phase I Study With Sorafenib in Addition to Vinflunine in Metastatic Transitional Cell Carcinoma of the Urothelial Tract
Conditions: Urothelial Cancer;   Bladder Cancer;   Renal Pelvis Cancer;   Ureter Cancer;   Urethra Cancer
Interventions: Drug: Vinflunine;   Drug: Sorafenib

Indicates status has not been verified in more than two years